Program
zinc lactate
Also written as “Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash”, “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash” and “Cetylpyridinium Chloride, Zinc Lactate and Hyaluronic Acid Mouthwash”.
Its studies are mostly in Gingivitis · Diabetes Mellitus, Type 2 · Gingival Diseases, led by Colgate Palmolive.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Colgate Palmolive | 41 open or running | phase 4since May 26, 2026 | Mar 27, 2023 | Jan 2, 2028phase 4 · NCT07619729 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Mar 27, 2023First study: phase 3 study in Plaque, AmyloidFirst studyNCT05821712 · 80 enrolled · Italy
- Jan 7, 2025Phase 3 study in GingivitisNCT06770114 · 80 enrolled · Italy
- Nov 24, 2025Phase 3 study in GingivitisNCT07263698 · 80 enrolled · Italy
- May 26, 2026Phase 4 study in Diabetes Mellitus, Type 2NCT07619729 · 10,000 planned · United States
Ahead
- Jan 2, 2028Primary completion: phase 4 study in Diabetes Mellitus, Type 2NCT07619729
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07619729Diabetes Mellitus, Type 2 · United States | 4 | By invitation | Jan 2, 2028 | 10,000 |
| NCT07263698Gingivitis · Italy | 3 | Completed | Feb 27, 2026 | 80 |
| NCT06770114Gingivitis · Italy | 3 | Completed | May 9, 2022 | 80 |
| NCT05821712Plaque, Amyloid · Italy | 3 | Completed | Sep 24, 2021 | 80 |
How it is read
Names in the registry
- “Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash”, 1 entry
- “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash”, 1 entry
- “Cetylpyridinium Chloride, Zinc Lactate and Hyaluronic Acid Mouthwash”, 1 entry
- “0.2% zinc lactate, 0.17% amine fluoride and 0.0275% sodium fluoride Mouthwash”, 1 entry
Conditions, from the studies’ own filings
- Gingivitis, 2 studies
- Diabetes Mellitus, Type 2, 1 study
- Gingival Diseases, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.